Notice2026-09513
Foreign-Trade Zone (FTZ) 21 Notification of Proposed Production Activity; Patheon API, Inc.; (Meloxicam, Xeloda, and Tamiflu); Florence, South Carolina
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 13, 2026
Issuing agencies
Commerce DepartmentForeign-Trade Zones Board
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 92 (Wednesday, May 13, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 92 (Wednesday, May 13, 2026)]
[Notices]
[Page 27017]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-09513]
[[Page 27017]]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-45-2026]
Foreign-Trade Zone (FTZ) 21 Notification of Proposed Production
Activity; Patheon API, Inc.; (Meloxicam, Xeloda, and Tamiflu);
Florence, South Carolina
Patheon API, Inc. submitted a notification of proposed production
activity to the FTZ Board (the Board) for its facility in Florence,
South Carolina within Subzone 21J. The notification conforming to the
requirements of the Board's regulations (15 CFR 400.22) was received on
April 15, 2026.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status material(s)/component(s) and
specific finished product(s) described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via <a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>. The proposed finished
products and materials/components would be added to the production
authority that the Board previously approved for the operation, as
reflected on the Board's website.
The proposed finished products include: Oseltamivir Phosphate
Shikimic Acid; Capecitabine; and Meloxicam Spray Dried Intermediate
(duty free).
The proposed foreign-status materials/components include: Eec-
cetamidoazide Shikimic Acid; Aromatic crystaline acetylfuranoside; Non-
aromatic crystalline acetylfuranoside; Sulphobutyl-ether-b
cyclodextrin; Flucytosine; and Meloxicam (duty free).
The request indicates that certain materials/components are subject
to duties under section 122 of the Trade Act of 1974 (Section 122) or
section 301 of the Trade Act of 1974 (section 301), depending on the
country of origin. The applicable section 122 and section 301 decisions
require subject merchandise to be admitted to FTZs in privileged
foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
<a href="/cdn-cgi/l/email-protection#ddbba9a79da9afbcb9b8f3bab2ab"><span class="__cf_email__" data-cfemail="b0d6c4caf0c4c2d1d4d59ed7dfc6">[email protected]</span></a>. The closing period for their receipt is June 22, 2026.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact John Frye at <a href="/cdn-cgi/l/email-protection#da90b5b2b4f49ca3a8bf9aaea8bbbebff4bdb5ac"><span class="__cf_email__" data-cfemail="feb4919690d0b8878c9bbe8a8c9f9a9bd0999188">[email protected]</span></a>.
Dated: May 11, 2026.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2026-09513 Filed 5-12-26; 8:45 am]
BILLING CODE 3510-DS-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 13, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.